10.21 USD
↘ 0.15 (1.45%)AT CLOSE (11:59 AM EDT)
Shares of Atrium Therapeutics, Inc. Common Stock (RNA) are trading at $10.22. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Sep 14, 2026.